• Je něco špatně v tomto záznamu ?

Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity

M. Bratova, K. Brat, K. Hurdalkova, M. Barinova, M. Drosslerova, J. Kultan, M. Wanke, L. Koubkova, J. Krejci, M. Svaton

. 2022 ; 11 (5) : 451-458. [pub] 20211102

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033239

Purpose: Aim was to analyze demographic and tumor characteristics, treatment, and survival of patients with lung cancer younger than 40 years of age (U40) compared to older subgroups (41-70 and >70 years). Methods: We analyzed data of young patients diagnosed and treated in 2011-2019 in five pneumo-oncology centers in Czechia. Standard descriptive statistics, chi-squared test, Fisher exact test, and Kaplan-Meier survival analysis were used. p-Values <0.05 were considered significant. These data were compared with two control subgroups (cohort 1: 41-70 years, cohort 2: >70 years). Results: We identified 66 patients U40, 61 with non-small cell lung cancer (NSCLC)-50.8% men, mean age 34.6 years, 54.1% nonsmokers, daily good performance status, and 82% in stage IV. Adenocarcinomas dominated, endothelial growth factor receptor (EGFR) positivity was less common than in older groups contrary to anaplastic lymphoma kinase (ALK) mutations. Median progression-free survival was 3.7 months (vs. 4.9 and 6.2 months; p = 0.006) and overall survival reached 11.7 months (vs. 22.3 and 27.3 months; p < 0.001). Young patients in stage IV and never-smokers had shorter survival than older patients. Conclusion: Patients with NSCLC U40 had significantly worse prognosis than older patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033239
003      
CZ-PrNML
005      
20230131151809.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/jayao.2021.0069 $2 doi
035    __
$a (PubMed)34726512
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bratova, Monika $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000019994480X
245    10
$a Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity / $c M. Bratova, K. Brat, K. Hurdalkova, M. Barinova, M. Drosslerova, J. Kultan, M. Wanke, L. Koubkova, J. Krejci, M. Svaton
520    9_
$a Purpose: Aim was to analyze demographic and tumor characteristics, treatment, and survival of patients with lung cancer younger than 40 years of age (U40) compared to older subgroups (41-70 and >70 years). Methods: We analyzed data of young patients diagnosed and treated in 2011-2019 in five pneumo-oncology centers in Czechia. Standard descriptive statistics, chi-squared test, Fisher exact test, and Kaplan-Meier survival analysis were used. p-Values <0.05 were considered significant. These data were compared with two control subgroups (cohort 1: 41-70 years, cohort 2: >70 years). Results: We identified 66 patients U40, 61 with non-small cell lung cancer (NSCLC)-50.8% men, mean age 34.6 years, 54.1% nonsmokers, daily good performance status, and 82% in stage IV. Adenocarcinomas dominated, endothelial growth factor receptor (EGFR) positivity was less common than in older groups contrary to anaplastic lymphoma kinase (ALK) mutations. Median progression-free survival was 3.7 months (vs. 4.9 and 6.2 months; p = 0.006) and overall survival reached 11.7 months (vs. 22.3 and 27.3 months; p < 0.001). Young patients in stage IV and never-smokers had shorter survival than older patients. Conclusion: Patients with NSCLC U40 had significantly worse prognosis than older patients.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a anaplastická lymfomová kináza $7 D000077548
650    12
$a nemalobuněčný karcinom plic $x genetika $x patologie $7 D002289
650    _2
$a erbB receptory $x genetika $7 D066246
650    12
$a nádory plic $7 D008175
650    _2
$a mutace $7 D009154
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a lidé středního věku $7 D008875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Brat, Kristian $u Department of Respiratory Diseases, University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Hurdalkova, Karolina $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic
700    1_
$a Barinova, Magda $u Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic
700    1_
$a Drosslerova, Marie $u Department of Respiratory Medicine, Thomayer University Hospital, Prague, Czech Republic $u 1st Faculty of Medicine, Charles University, Praque, Czech Republic
700    1_
$a Kultan, Juraj $u Department of Respiratory Medicine, University Hospital Olomouc, Olomouc, Czech Republic $u Faculty of Medicine, Palacky University, Olomouc, Czech Republic
700    1_
$a Wanke, Matyas $u Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic $u Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic
700    1_
$a Koubkova, Leona $u Department of Pneumology, University Hospital Motol, Prague, Czech Republic $u 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Krejci, Jana $u Department of Pneumology and Thoracic Surgery, Bulovka Hospital, Prague, Czech Republic
700    1_
$a Svaton, Martin $u Department of Pneumology, University Hospital Pilsen, Pilsen, Czech Republic $u Faculty of Medicine, Charles University in Prague, Pilsen, Czech Republic
773    0_
$w MED00207063 $t Journal of adolescent and young adult oncology $x 2156-535X $g Roč. 11, č. 5 (2022), s. 451-458
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34726512 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151805 $b ABA008
999    __
$a ok $b bmc $g 1891799 $s 1184574
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 11 $c 5 $d 451-458 $e 20211102 $i 2156-535X $m Journal of adolescent and young adult oncology $n J Adolesc Young Adult Oncol $x MED00207063
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace